Diagnosis and treatment of differentiated thyroid carcinoma;Diagnostik und therapie differenzierter schilddrüsenkarzinome

Internist

Volumn 43, Issue 2, 2002, Pages 174-185

  Mann, K ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; OCTREOTIDE; PACLITAXEL; STREPTOZOCIN; VINCRISTINE; VINDESINE;

ANAPLASTIC CARCINOMA; CANCER RISK; CANCER STAGING; ECHOGRAPHY; HUMAN; PROGNOSIS; REVIEW; SIPPLE SYNDROME; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TREATMENT INDICATION;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM STAGING; PATIENT CARE TEAM; PROGNOSIS; THYROID NEOPLASMS;

EID: 0036965667     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-001-0526-0     Document Type: Review

References (44)

1. Ain KB, Egorin MJ, de Simone PA (2000) Treatment of anaplastic thyroid carcinoma with paclitaxal: Phase 2 trial using 96-hour infusion. Thyroid 10: 587-594
2. Brandt-Mainz K, Müller SP, Görges R, Saller B, Bockisch A (2000)The value of luorine-18 Gruorodesoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 27: 490-496
3. Colletta G, Sciacchitano S, Palmirotta R et al. (1994) Analysis of adenomatous polyposis coli gene in thyroid tumours. Br J Cancer 70: 1085-1088
4. Cusick EL, MacIntosh CA, Krukowski ZH, Williams VM, Ewen SW, Matheson NA (1990) Management of isolated thyroid swellings: a prospective six year study of fine needle aspiration cytology in diagnosis. BMJ 301: 318-321
5. Dralle H, Gimm O, Simon D (1998) Prophylactic thyreoidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: The German and Austrian experience. World J Surg 22: 744-751
6. Engelbach M, Görges R, Forst T et al. (2000) Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitoniri measurement. J Clin Endocrinol Metab 85: 1890-1894
7. Frank-Raue K, Raue F (2002) Medikamentöse Therapie beim medullären Schilddrüsenkarzinom. In: Feldkamp I, Scherbaum WA, Schott M (Hrsg) Medulläres Schilddrüsenkarzinom. de Gruyter, Stuttgart
8. Führer D, Holsapfel HP, Ruschenburg J, Paschke R (2001) Diagnostik des Schilddrüsenknotens. Dtsch Ärztebl 38: 2094-2100
9. Hahm JR, Lee MS, Min YK et al. (2001) Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoms in patients with modular thyroid diseases. Thyroid 11: 73-80
10. Harness JK, Thompson NW, McLeod MK, Pasieka JL, Fukuuchi A (1992) Differentiated thyroid carcinoma in children and adolescents. World J Surg 16: 547-553
11. Hermanek P, Sobin LH (1997) TNM classification of malignant tumurs. Springer, Berlin Heidelberg New York, pp 33-34
12. Hershman JM, Bladh WH, Gordon HE (1992) In: Haskell CM (ed) Thyroid gland. Cancer treatment, 3rd edn. Saunders, Philadelphia, pp 406-413
13. Hoelzer S, Reiners C, Mann K et al. (2000) Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group. Cancer 89: 192-201
14. Höppner W (2001) Molekulare Routinediagnostik in der Endokrinologie. J Lab Med 25: 380-386
15. Langsteger W, Költringer P, Wolf G et al. (1993) The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. Eur J Cancer 29: 1547-1553
16. Liaw D, Marsh DJ, Li J et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: 64-67
17. LiVolsi VA, Brooks JJ, Arendash-Durand B (1987) Anaplastic thyroid tumurs immuno-histology. Am J Clin Pathol 87: 434
18. Lupoli G, Cascone E, Arlotta F, Vitale G, Celetanol L, Salvatore M, Lombardi G (1996) Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon α-2b and octreoxide. Cancer 78: 1114-1118
19. Machens A, Hinze R, Lautenschläger C, Thomusch O, Dralle H (2001) Prophylactic completion thyreoidectomy for differentiated carcinoma: Prediction of extrathyreoidal soft tissue infiltrates. Thyroid 11: 381-384
20. Mann K (1994) Schilddrüsenkarzinome. In: Wilmans W, Huhn D, Wilms K (Hrsg) Internistische Onkologie. Thieme, Stuttgart New York, S 600-611
21. Mayr B, Brabant G, von zur Mühlen A (1999) Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease. Eur J Endocrinol 141: 286-289
22. Mazzaferri EL (1999) An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 9: 421-427
23. Modigliani E, Cohen R, Joannidis S et al.(1992) Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma. Clin Endocrinol 36: 183-186
24. Möller L (2000) Chemotherapie des metastasierenden medullären Schilddrüsenkarzinoms mit Cyclophosphamid, Vincristin und Dacarbazin. Exp Clin Endocrinol Diabetes (Suppl) 108: 167
25. Nascimento MC, Bisi H, Alves V, Longatto-Filho A, Kanamura CT, Medeiros-Neto G (2001) Differential immunohistochemistry reactivity of Galectin-3 in Hurthle cell adenomas and carcinomas. Endocr Soc 2: 531
26. Orlandi F, Caraci P, Berruti A, Puligheddu B, Pivano G, Dogliotti L, Angeli A (1994) Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. Ann Oncol 5: 763-765
27. Petrich T, Börner AR, Weckesser E et al. (2001) Follow-up of thyroid cancer patients using rhTSH-preliminary results. Nuklearmedizin 40: 7-14
28. Raber W, Kaserer K, Niederle B, Vierhapper H (2000) Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a propective study of one hundred twenty patients. Thyroid 10: 709-712
29. 131J therapy of thyroid cancer patients. Q J Nucl Med 43: 324-335
30. Reiners C (1998) Sequel of Chernobyl. Internist 39: 592-593
31. Rendl I, Bier D, Groh T, Reiners C (1998) Rapid urinary iodide test. J Clin Endocrinol Metab 83: 1007-1012
32. Ringel MD, Ladenson PW, Levine MA (1998) Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonudeic acid in periphal blood. J Clin Endocrinol Metab 83: 4435-4442
33. Saller B (2001) Treatment with cytotoxic drugs. In: Biersach HJ, Grünwald F (Hrsg) Thyroid cancer in the year 2000. Springer, Berlin Heidelberg New York Tokio
34. Schlumberger M, Abdelmoumene N, Delisle MJ, Conette IE (1995) Treatment of advanced medullary thyroid cancer with an aternating combination of 5 FU-streptozocin and 5 FV-dacarbacin. Br J Cancer 71: 363-365
35. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297-306
36. Schlumberger M, Ricard M, Pacini F (2000) Clinical use of recombinant human TSH in thyroid cancer patients. Eur J Endocrinol 143: 557-563
37. Schneider AB (1991) Carcinoma of follicular epithelium - Pathogenesis in Werner and Ingbar's. In: Braverman LE, Utiger RD (eds) The thyroid. Lipincott, Philadelphia, pp 1121-1129
38. Solomon BL, Wartofsky L, Burman KD (1996) Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 83: 333-339
39. Spencer C (2001) Thyroid testing guidelines: National Academy of Clinical Biochemistry
40. Takano T, Miyanchi A, Yokozawa T et al. (1998) Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transscription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. Cancer Res 58: 4913-4917
41. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhansl A, Niederle B (1997) Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82: 1589-1593
42. World Health Organization (1990) ICD-0-2 International classification of disease of oncology, 2nd edn. WHO, Geneva
43. Wu LT, Averbuch SD, Ball DW, de Bustros A, Baylin SB, McGuire WP (1994)Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine. Cancer 73: 432-436
44. Ziegler R, Landgraf R, Müller OA, von zur Mühlen A (1997) Rationelle Therapie in der Endokrinologie. Deutsche Gesellschaft für Endokrinologie (Hrsg) Thieme, Stuttgart